Company
Alnylam
We are a biopharmaceutical company driven by science and committed to delivering transformational medicines for patients.
Also known as Alnylam Pharmaceuticals, Inc
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2002
- Legal name
- Alnylam Pharmaceuticals, Inc
- alnylam.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Alnylam has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases in a different way - by silencing the genes that cause or contribute to them.
About the company
- Status notes
- Alnylam IPO and listing on the Nasdaq exchange
Products
- Other
- AMVUTTRA (vutrisiran)
- Other
- GIVLAARI (givosiran)
- Other
- ONPATTRO (patisiran)
- Other
- OXLUMO (lumasiran)
Loading relationship preview